{
  "id": "sodium-potassium-atpase",
  "title": "Sodium–Potassium ATPase",
  "lang": "en",
  "source_lang": "en",
  "summary": "Sodium–potassium ATPase is a membrane enzyme that uses ATP to export sodium and import potassium, sustaining electrical activity, transport, and cell volume.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "Na⁺/K⁺-ATPase",
    "sodium–potassium pump",
    "sodium pump",
    "Na,K-ATPase"
  ],
  "generated_at": "2026-11-03",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/sodium-potassium-atpase/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/sodium-potassium-atpase/",
      "json": "https://aiwiki.page/zh/sodium-potassium-atpase.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Sodium–potassium ATPase is an integral cell-membrane enzyme that uses the energy of adenosine triphosphate (ATP) to transport sodium ions out of cells and potassium ions into them. In its normal transport cycle, one ATP molecule supports the export of three sodium ions and the import of two potassium ions. Both movements oppose the ions’ electrochemical gradients. Because each cycle moves one net positive charge outward, the pump is electrogenic: its operation directly contributes to the electrical potential across the membrane.\n\nThe enzyme is fundamental to animal physiology. It maintains the ionic conditions required for nerve and muscle activity, supplies the sodium gradient that drives the transport of nutrients and other solutes, and helps prevent excessive cellular swelling. Its function links molecular energy conversion to electrical signaling, epithelial transport, and whole-body electrolyte balance. The pump is also a major pharmacological target and a site at which inherited molecular defects can disturb nervous-system function."
    },
    {
      "heading": "Discovery and experimental foundations",
      "text": "The identification of sodium–potassium ATPase emerged from efforts to explain why living cells maintain high internal potassium concentrations and low internal sodium concentrations despite continuous passive ion leakage. Experiments on muscle, red blood cells, and large nerve fibers had established that this unequal distribution required metabolic energy. Removing oxygen or interfering with ATP production impaired ion extrusion, indicating that the membrane contained an energy-dependent transport mechanism rather than merely a selective barrier.\n\nIn 1957, the Danish physiologist Jens Christian Skou reported an ATP-hydrolyzing activity in membrane preparations from crab nerves. Its activity depended on magnesium and was stimulated by the appropriate combination of sodium and potassium. These properties matched the requirements expected of an enzyme responsible for sodium extrusion and potassium uptake. The discovery connected a measurable biochemical reaction with an established physiological transport process. Skou received half of the 1997 Nobel Prize in Chemistry for the discovery of the ion-transporting enzyme; Paul Boyer and John Walker shared the other half for work on ATP synthesis.\n\nSubsequent experiments linked ATP breakdown quantitatively to ion movement. Radioactive sodium and potassium tracers allowed researchers to measure transport across intact membranes, while biochemical assays measured the release of inorganic phosphate. Studies of red blood cells were particularly useful because their relatively simple structure made it easier to relate membrane transport to cellular ATP consumption. Experiments eventually established the normal coupling ratio of three sodium ions exported and two potassium ions imported per ATP hydrolyzed.\n\nA crucial mechanistic development was the discovery of a transient phosphorylated enzyme intermediate. The phosphoryl group from ATP is transferred to the pump itself before being released as inorganic phosphate. Together with evidence that sodium acts from the cytoplasmic side and potassium from the extracellular side, this supported a cycle involving alternating ion-binding conformations. The resulting Post–Albers model, associated with the work of R. Wayne Albers and Robert Post, remains the principal framework for explaining the reaction.\n\nModern experiments combine these classical approaches with electrical recording and structural biology. Voltage-clamp measurements isolate pump-generated current, while rapid solution exchange reveals how individual steps respond to ions and membrane voltage. X-ray crystallography and cryo-electron microscopy provide structural snapshots of the enzyme in different states. No single method records the entire molecular cycle directly: its mechanism is reconstructed by integrating transport measurements, chemical kinetics, electrical signals, and structures."
    },
    {
      "heading": "Subunit organization and molecular architecture",
      "text": "Sodium–potassium ATPase belongs to the P-type ATPase family, whose members form a phosphorylated intermediate during transport. The functional core contains a catalytic α subunit and an associated β subunit. In many tissues, a small FXYD-family protein associates with this core and modifies its kinetic properties. The αβ complex is sufficient for the principal transport reaction; larger assemblies can occur, but an obligatory dimer is not required to explain the basic pumping cycle.\n\nThe α subunit is a protein of roughly 1,000 amino acids, with a molecular mass near 110 kilodaltons. It contains ten membrane-spanning helices, conventionally designated M1–M10. These helices surround the ion-binding sites and form pathways through which sodium and potassium enter and leave. Most of the protein’s mass lies on the cytoplasmic side, where three major domains carry out ATP-dependent conformational work. The nucleotide-binding, or N, domain binds ATP; the phosphorylation, or P, domain contains the conserved aspartate that becomes phosphorylated; and the actuator, or A, domain helps control conformational changes and dephosphorylation.\n\nThe ion-binding region is not a rigid channel with permanently open ends. Instead, oxygen atoms from amino-acid side chains, backbone groups, and associated water molecules coordinate the transported ions. Movements of the transmembrane helices alter both access to these sites and their preference for sodium or potassium. Two binding regions can accommodate either sodium or potassium at different stages, whereas the third sodium-binding site has a distinct role in completing the three-sodium transport configuration.\n\nThe β subunit is a glycosylated membrane protein with one transmembrane helix and a large extracellular domain. It supports proper folding, assembly, and delivery of the pump to the cell surface. Its extracellular carbohydrate chains contribute to maturation and stability, while interactions between β and α influence the behavior of the assembled complex. The β subunit is therefore not simply a passive anchor, even though ATP hydrolysis occurs in α.\n\nFXYD proteins are considerably smaller, usually with a single transmembrane helix. Their family name derives from a conserved amino-acid motif near the extracellular end. Different FXYD members alter apparent sodium or potassium affinity, maximal activity, or responses to regulation. Membrane lipids also matter: interactions with phospholipids and cholesterol help stabilize the pump and affect its conformational transitions. Consequently, purified enzyme behavior depends partly on the surrounding lipid environment, not only on the amino-acid sequence."
    },
    {
      "heading": "The ATP-driven transport cycle",
      "text": "The pump operates through alternating access: its ion-binding sites communicate with one side of the membrane and then the other, without forming a continuously open aqueous pore. The two broad conformational families are called E1 and E2. These labels denote groups of related states rather than just two rigid structures. E1 favors sodium binding from the cytoplasm, whereas E2 favors potassium binding from outside.\n\nA simplified physiological cycle begins with the inward-accessible E1 state binding three cytoplasmic sodium ions. ATP binds to the cytoplasmic catalytic apparatus, generally with magnesium as an essential associated ion. Transfer of ATP’s terminal phosphoryl group to a conserved aspartate in the P domain produces a phosphorylated intermediate, and ADP is released. During these transitions, the bound sodium ions become occluded: they are enclosed within the protein and cannot freely exchange with either bulk solution.\n\nThe enzyme then undergoes a major rearrangement toward an outward-facing phosphorylated state, usually represented as E2P. Sodium affinity decreases, and the three sodium ions are released extracellularly. This sequence illustrates how ATP chemistry is coupled to transport. ATP does not simply supply a nonspecific burst of energy; phosphorylation changes the relative stability of protein conformations, thereby changing which side can access the binding sites and how strongly those sites bind their ions.\n\nTwo extracellular potassium ions subsequently occupy the outward-accessible sites. Potassium binding promotes closure of the extracellular pathway and stimulates hydrolysis of the phosphorylated aspartate. Inorganic phosphate is released, leaving a potassium-occluded E2 state. The enzyme then returns toward E1, with ATP binding helping accelerate this transition under normal conditions. Opening toward the cytoplasm lowers potassium affinity and releases both potassium ions inside.\n\nThis cycle yields the familiar three-to-two transport ratio, but individual reactions can be studied under conditions in which the complete cycle does not proceed normally. Depending on ion composition, nucleotide availability, and voltage, experimental preparations can show exchange reactions, partial cycles, or uncoupled ion movements. These behaviors reveal the reversibility and branching possibilities of the molecular machinery; they do not replace the standard stoichiometry of ordinary forward pumping.\n\nThe distinction between a pump and an ion channel is central. Channels can allow very large numbers of ions to pass rapidly down an electrochemical gradient. Sodium–potassium ATPase normally moves only a few ions per catalytic cycle and must coordinate ion binding, occlusion, phosphorylation, and release. Under favorable laboratory conditions, turnover can reach tens to hundreds of cycles per second, but it varies substantially with temperature, isoform, membrane composition, and experimental conditions."
    },
    {
      "heading": "Energetics and electrical consequences",
      "text": "The pump converts the chemical free energy of ATP hydrolysis into stored electrochemical energy. Its overall transport reaction can be represented schematically as\n\n\\[\\mathrm{ATP}+3\\mathrm{Na}_{i}^{+}+2\\mathrm{K}_{o}^{+} +\\mathrm{H_2O} \\rightarrow \\mathrm{ADP}+\\mathrm{P_i}+3\\mathrm{Na}_{o}^{+}+2\\mathrm{K}_{i}^{+}.\\]\n\nHere \\(i\\) and \\(o\\) indicate intracellular and extracellular compartments. This shorthand suppresses some details of protonation and magnesium binding, which depend on solution conditions.\n\nBoth concentration differences and electrical potential oppose normal pumping. Many mammalian cells contain approximately 5–15 millimolar sodium and 120–150 millimolar potassium, whereas extracellular fluid contains about 135–145 millimolar sodium and 3.5–5 millimolar potassium. Values vary with cell type and physiological state. The cell interior is also usually electrically negative, so moving net positive charge outward requires additional work.\n\nUsing activities to express the chemical gradients, the reversible work per mole of forward transport cycles is\n\n\\[\\Delta G_{\\mathrm{transport}} = 3RT\\ln\\!\\left(\\frac{a_{\\mathrm{Na},o}}{a_{\\mathrm{Na},i}}\\right) + 2RT\\ln\\!\\left(\\frac{a_{\\mathrm{K},i}}{a_{\\mathrm{K},o}}\\right) -FV_m,\\]\n\nwhere \\(R\\) is the gas constant, \\(T\\) is absolute temperature, \\(F\\) is the Faraday constant, and \\(V_m\\) is intracellular minus extracellular electrical potential. The electrical term is \\(-FV_m\\) because one net positive charge moves outward per cycle. Forward pumping is energetically favorable when the sum of this transport cost and the Gibbs free-energy change of ATP hydrolysis is negative.\n\nThe ATP hydrolysis free energy inside cells is not a fixed standard-state value. It depends on ATP, ADP, phosphate, magnesium, and other conditions, and commonly provides roughly 50–60 kilojoules per mole under cellular conditions. Typical ion gradients require a substantial fraction of that energy. If the gradients become sufficiently steep, or the ATP-to-ADP ratio sufficiently low, the driving force for forward transport diminishes. Under specially imposed experimental conditions, the enzyme can reverse and couple downhill ion movement to ATP synthesis.\n\nBecause the transport ratio is unequal, pump activity produces an outward electric current that tends to make the cell interior more negative. Nevertheless, the resting membrane potential is not generated by the pump current alone. In many cells, selective potassium permeability and other passive conductances determine most of its immediate value. The pump’s deeper contribution is to maintain the ion gradients on which these conductances act. Blocking the pump therefore has an immediate electrical effect and a slower, often much larger effect as the gradients dissipate."
    },
    {
      "heading": "Roles in excitable cells, transport epithelia, and cell volume",
      "text": "In a neuron, sodium enters and potassium leaves during electrical activity. Individual action potentials are produced primarily by the opening and closing of ion channels, not by a rapid reversal of the pump cycle. Sodium–potassium ATPase restores and maintains the gradients that make repeated firing possible. Increased intracellular sodium after activity stimulates pumping, linking the recovery workload to the amount of preceding ion entry. Sustained pump activity can also contribute to a prolonged afterhyperpolarization following trains of impulses.\n\nThe sodium gradient supports many forms of secondary active transport. In this arrangement, a transporter allows sodium to move down its electrochemical gradient while coupling that movement to the uphill transport of another substance. Sodium-dependent uptake of glucose and amino acids in intestinal and renal epithelia is a major example. Other sodium-coupled systems contribute to neurotransmitter clearance and the regulation of intracellular calcium and pH. The pump supplies energy indirectly to these processes rather than binding and transporting all of their substrates itself.\n\nEpithelial cells use spatial organization to turn cellular pumping into directed transport across an entire tissue. In much of the kidney and intestine, sodium–potassium ATPase is concentrated in the basolateral membrane, facing the interstitial fluid rather than the lumen. Sodium enters through transporters or channels in the apical membrane and is then exported basolaterally by the pump. Potassium channels recycle much of the imported potassium. Together, these pathways allow net sodium absorption, with accompanying anions and water following through suitable routes.\n\nIn the kidney, this arrangement underlies the recovery of filtered sodium along the nephron. Transport mechanisms differ among segments: proximal tubular cells recover large quantities of sodium together with nutrients and other solutes, while downstream segments make finer adjustments to electrolyte excretion. The pump is thus a final common energy source for several distinct apical transport systems. Its heavy ATP demand helps explain the close relationship between renal transport work, oxygen consumption, and mitochondrial function.\n\nThe pump also contributes to cell-volume stability. Intracellular proteins and other relatively impermeant solutes create osmotic tendencies that would favor ion and water accumulation if membrane transport were uncontrolled. By maintaining low cytoplasmic sodium, the pump helps balance passive leaks and restrict excessive swelling. This pump–leak balance depends on the permeability of the membrane and the distribution of other solutes; it is not simply a matter of counting three exported ions against two imported ions. When ATP production fails, sodium and accompanying solutes can accumulate, and water enters by osmosis."
    },
    {
      "heading": "Isoforms and tissue specialization",
      "text": "Humans have four genes encoding catalytic α subunits: ATP1A1, ATP1A2, ATP1A3, and ATP1A4. Their products are conventionally called α1 through α4. The isoforms preserve the same basic catalytic architecture but differ in tissue distribution, transport kinetics, regulation, and sensitivity to some inhibitors. These distinctions allow the sodium pump to meet different physiological demands without changing its fundamental three-sodium, two-potassium coupling scheme.\n\nThe α1 isoform is widely expressed and supports basic ion homeostasis in many cell types. It is prominent in transporting epithelia, including the kidney. The α2 isoform is important in skeletal and cardiac muscle and is also strongly associated with astrocytes in the nervous system. In muscle, its location and regulation help it respond to ionic changes accompanying contraction. In astrocytes, α2-containing pumps participate in potassium handling and support the ionic environment required for neuronal activity and transmitter uptake.\n\nThe α3 isoform is particularly important in neurons. Compared with α1 under many experimental conditions, α3 has a lower apparent affinity for intracellular sodium, allowing it to contribute strongly when sodium rises during sustained activity. This distinction is functional rather than absolute: the behavior of each isoform depends on its β subunit, FXYD partner, voltage, and local membrane environment. Neurons may express more than one α isoform, so the total pump response reflects the combined properties and spatial distribution of multiple populations.\n\nThe α4 isoform is strongly associated with the male germ line and is important for sperm function. Experimental studies link it to the ionic gradients and membrane properties needed for sperm motility. Its specialized distribution illustrates that sodium–potassium ATPase is not merely a uniform housekeeping enzyme. In some cells, particular isoforms serve highly differentiated tasks that cannot be fully replaced by broadly expressed variants.\n\nThree human genes, ATP1B1, ATP1B2, and ATP1B3, encode β-subunit isoforms. The β2 protein was also identified as the adhesion molecule on glia, or AMOG, reflecting functions associated with cell-surface organization in addition to its role in the pump. The β isoform can influence assembly, trafficking, and ion-binding behavior of the αβ complex. FXYD proteins add a further layer of tissue specificity; for example, FXYD1 is prominent in muscle, whereas FXYD2 is strongly associated with the kidney.\n\nSubcellular placement is as important as expression level. Pumps can occupy membrane regions near channels, exchangers, or junctional structures, allowing them to respond to local ion changes that are not captured by a measurement of average cytoplasmic concentration. Such organization helps explain why two pump isoforms with broadly similar catalytic capabilities can have different physiological effects."
    },
    {
      "heading": "Regulation by ions, phosphorylation, and membrane trafficking",
      "text": "The most immediate regulators of sodium–potassium ATPase are its own transported ions. An increase in intracellular sodium generally raises activity by increasing occupancy of inward-facing sodium-binding sites. Extracellular potassium is required for completion of the ordinary cycle, and changes in its concentration influence both binding and turnover. ATP availability and membrane voltage also alter reaction rates. These effects provide direct feedback: ion entry increases the substrate supply for the mechanism that removes it.\n\nRegulation does not occur at a single universally limiting step. Depending on conditions, sodium binding, conformational rearrangement, potassium deocclusion, or another transition can become rate-limiting. Temperature and the surrounding lipid environment modify these rates. Consequently, a change described experimentally as altered “sodium affinity” may reflect several linked transitions rather than a simple change in the strength of one isolated binding site.\n\nReversible protein phosphorylation provides a second regulatory layer. This regulatory phosphorylation must be distinguished from the transient phosphorylation of the catalytic aspartate during every transport cycle. Protein kinases can modify the α subunit, associated proteins, or trafficking machinery. The outcome depends on the cell type and signaling context: phosphorylation can change catalytic behavior, alter membrane retention, or promote internalization.\n\nFXYD1, also known as phospholemman, is a well-studied example in cardiac muscle. In its unphosphorylated state, it can reduce the apparent affinity of associated pumps for intracellular sodium. Phosphorylation by signaling pathways involving protein kinase A or protein kinase C relieves this inhibition under relevant conditions. This mechanism helps coordinate sodium extrusion with changes in cardiac activity, during which sodium entry and calcium cycling both increase.\n\nHormones can also regulate the number of pumps present at the surface. In renal epithelia, aldosterone influences the expression and transport machinery that support sodium reabsorption, including sodium–potassium ATPase. Other signals, including dopamine in renal cells, can promote changes in pump phosphorylation and trafficking that reduce surface transport capacity in particular contexts. These responses are integrated with regulation of apical sodium entry; changing only the basolateral pump would not fully determine transepithelial sodium movement.\n\nOver longer timescales, changes in gene expression, protein synthesis, assembly, and degradation adjust pump abundance and isoform composition. Cellular stress can reduce ATP supply or alter membrane lipids, indirectly impairing transport even when the enzyme itself remains intact. These regulatory levels operate on different timescales, from rapid changes in substrate occupancy to slower changes in protein abundance, allowing the same molecular machinery to accommodate both moment-to-moment activity and sustained physiological adaptation."
    },
    {
      "heading": "Inhibitors, toxins, and pharmacological action",
      "text": "Cardiac glycosides are the best-known inhibitors of sodium–potassium ATPase. They include ouabain and digoxin, compounds with a steroid-like core and, in many cases, attached sugar groups. Their binding site is accessible from the extracellular side of the α subunit. Binding stabilizes particular outward-facing conformations and interrupts productive cycling. Potassium occupancy and other conformational factors influence inhibitor affinity, so inhibition depends partly on the ionic conditions surrounding the enzyme.\n\nDigoxin’s established cardiac action follows from the pump’s relationship to sodium-dependent calcium transport. Inhibiting a fraction of sodium pumps increases intracellular sodium and reduces the electrochemical driving force available to the sodium–calcium exchanger for calcium extrusion. This can increase calcium availability for contraction. The sequence is indirect: digoxin does not increase contractility by serving as a calcium-channel agonist or by supplying metabolic energy to the muscle.\n\nThe same pathway can become disruptive when pump inhibition is excessive. Altered sodium and potassium balance, changes in membrane excitability, and intracellular calcium accumulation can contribute to cardiac rhythm disturbances. Cardiac glycosides therefore have a narrow therapeutic range. Their pharmacological effects also involve autonomic influences, so the overall response of the heart cannot be reduced to the contractile action alone.\n\nSensitivity to cardiac glycosides differs among species and isoforms. Certain rodent α1 pumps, for example, are much less sensitive to ouabain than many corresponding mammalian pumps. Amino-acid substitutions near the binding region account for important parts of this difference. Such variation matters when interpreting experiments: a concentration that strongly inhibits a human pump preparation may have a different effect in mouse or rat tissue.\n\nOther substances inhibit the enzyme through different mechanisms. Orthovanadate can stabilize states related to the phosphoryl-transfer reaction and has been widely used to investigate P-type ATPases, although it is not specific to the sodium pump. Palytoxin produces a more unusual effect. By binding to sodium–potassium ATPase, it can disrupt the coordination of the gates that normally enforce alternating access, converting the pump into a poorly selective cation-conducting pathway. This demonstrates the importance of preventing simultaneous access from both sides of the membrane.\n\nBeyond transport inhibition, cardiac-glycoside binding has been investigated as a trigger for intracellular signaling, including proposed interactions involving Src-family kinases and reactive oxygen species. Cellular signaling responses have been reported, but their dependence on direct protein interactions, local ion changes, and experimental conditions remains under investigation. These proposed roles are distinct from the firmly established function of the enzyme as an ATP-driven ion transporter."
    },
    {
      "heading": "Inherited disorders and consequences of pump failure",
      "text": "Pathogenic variants in sodium–potassium ATPase genes can produce disease because specialized tissues depend on particular pump isoforms. A variant may reduce protein abundance, interfere with folding or membrane delivery, alter ion affinity, or impair one of the catalytic transitions. The physiological outcome depends not only on how much activity is lost but also on which cells express the affected isoform and whether other isoforms can compensate.\n\nVariants in ATP1A2 cause a substantial proportion of familial hemiplegic migraine type 2. The α2 isoform’s role in astrocytes connects these variants to extracellular potassium regulation and the ionic support of glutamate uptake. Disruption of these processes can increase susceptibility to cortical spreading depolarization, a slowly propagating disturbance of cortical electrical activity associated with migraine aura. Not every ATP1A2 variant has the same functional consequence, and the clinical range extends beyond a single uniform presentation.\n\nPathogenic ATP1A3 variants are associated with several overlapping neurological syndromes. These include alternating hemiplegia of childhood, rapid-onset dystonia-parkinsonism, and CAPOS syndrome, whose name refers to cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss. The association between these disorders and α3 is consistent with the isoform’s importance in neuronal sodium recovery. Individual variants and affected protein regions differ, however, and a simple one-to-one correspondence between a measured transport defect and a clinical syndrome is often insufficient.\n\nSomatic mutations in ATP1A1 have been identified in some aldosterone-producing adrenal adenomas. In this setting, altered pump function can disturb membrane voltage and calcium-dependent processes involved in aldosterone secretion. Some disease-associated variants produce abnormal ion conductance as well as impaired ordinary pumping, illustrating that a mutated transporter may acquire a harmful leak pathway rather than merely lose activity.\n\nPump failure also occurs without a primary genetic defect. During severe ischemia, reduced oxygen and substrate delivery can lower ATP production. As sodium pumping weakens, sodium and water accumulate intracellularly, potassium gradients decline, and membrane depolarization develops. Sodium-dependent calcium extrusion may become less effective or reverse under appropriate ionic conditions, contributing to calcium accumulation. These changes interact with many other consequences of energy failure rather than constituting an isolated pump-specific disease process.\n\nResearch on these disorders uses biochemical assays, electrophysiology, structural analysis, animal models, and patient-derived cells. A central challenge is to connect a molecular alteration measured in an experimental system with the behavior of a differentiated tissue. Neurons, astrocytes, muscle cells, and endocrine cells impose different ionic workloads and express different partner proteins, so the same class of catalytic impairment can have markedly different consequences in each setting."
    }
  ],
  "links": [
    "cell-membrane",
    "enzyme",
    "adenosine-triphosphate",
    "electrochemical-gradient",
    "metabolism",
    "nobel-prize-in-chemistry",
    "erythrocyte",
    "x-ray-crystallography",
    "cryo-electron-microscopy",
    "protein",
    "amino-acid",
    "cholesterol",
    "hydrolysis",
    "ion-channel",
    "gas-constant",
    "faraday-constant",
    "gibbs-free-energy",
    "electric-current",
    "membrane-potential",
    "neuron",
    "action-potential",
    "secondary-active-transport",
    "glucose",
    "ph",
    "osmosis",
    "gene-expression"
  ],
  "sources": [],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}